Evommune, Inc. (EVMN) Shareholders’ equity 2024–2025
Evommune, Inc. (EVMN) shareholders’ equity at each fiscal year-end, per SEC filings.
$205.6MFY2025 · since FY2024: -$144.2M → $205.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $205.6M | +242.5% |
| FY2024 | -$144.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice